FDA Roundup: March 7, 2025
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Instructions for Use — Patient Labeling for Human Prescription Drug and Biological Products — Content and Format
Guidance for Industry – Labeling
Radioactive Drug Research Committee (RDRC) Program
Regulating the use of radioactive drugs in basic research
Activities Report of the Generic Drug Program (FY 2024) – FDARA Title VIII Sections 807 and 805
Section 807 of the FDA Reauthorization Act of 2017 (FDARA) requires the FDA to report on certain abbreviated new drug…
Activities Report of the Generic Drug Program | FDARA Title VIII Sections 807 and 805
Section 807 of the FDA Reauthorization Act of 2017 (FDARA) requires the FDA to report on certain abbreviated new drug…
UPS rolls out fuel surcharge hikes, processing fee changes
One expert said FedEx could be poised to match the increases, which include a higher late payment rate and fees…
Cargo theft reaching record levels, prompting calls for congressional action
Carriers and shippers urged congress to combat the issue by stepping up enforcement and creating a task force.
Monster takes patient approach to aluminum tariffs
The beverage company is “hedged” on the metal in 2025, but it is reviewing its pricing strategy.
US chip production targets at risk under Trump administration
As the president uses tariffs to push domestic manufacturing while calling for federal spending cuts, experts say the future of…
China sovereign AI
China invests in data centers with an infrastructure-driven approach to accelerate the development of its sovereign AI ecosystem.